Expression levels of miR-۲۲, miR-۳۰c, miR-۱۴۵, and miR-۵۱۹d and their possible associations with inflammatory markers among patients with coronary artery disease

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 188

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RYA-18-6_003

تاریخ نمایه سازی: 1 شهریور 1401

Abstract:

BACKGROUND: Coronary artery disease (CAD) is a leading cause of death around the world. Micro-ribonucleic acid (miRNA) can be involved in forming of atherosclerotic plaques, inflammation, cholesterol metabolism, and other mechanisms involved in CAD development. This study aimed to evaluate the expression level of miR-۲۲, miR-۳۰c, miR-۱۴۵, and miR-۵۱۹d and their possible association with inflammatory markers among patients with CAD.METHODS: The expression level of miR-۲۲, miR-۳۰c, miR-۱۴۵, miR-۵۱۹d, interleukin ۶ (IL-۶), and transforming growth factor beta (TGF-β) was determined in peripheral blood mononuclear cells (PBMCs) from ۴۶ patients with CAD and ۳۹ healthy controls using real-time quantitative polymerase chain reaction (qPCR) assay.RESULTS: ۵۳.۸% (n = ۲۱) and ۵۲.۲% (n = ۲۴) of controls and cases were men, respectively; the mean age was ۵۹.۸ ± ۷.۴ and ۵۷.۰ ± ۹.۸ years, respectively. The miRNA expression pattern of each group showed significantly different expression profiles. In the CAD patients group, miR-۲۲, miR-۳۰c, and miR-۱۴۵ were down-regulated compared to the control group. On the opposite, miR-۵۱۹d was up-regulated in patients with CAD compared to the control group. Our results also showed that the expression levels of IL-۶ and TGF-β were up-regulated among patients with CAD compared to the control group. In addition, the expression of miR-۱۴۵ and miR-۵۱۹d had a significantly negative and positive correlation with TGF-β and IL-۶, respectively.CONCLUSION: The change in expression levels of miR-۲۲, miR-۳۰c, miR-۱۴۵, and miR-۵۱۹d in PBMCs of patients with CAD could be considered as a potential biomarker for CAD.

Keywords:

Coronary Artery Diseases , miRNAs , Peripheral blood mononuclear cell

Authors

Saied Ghorbani

Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Seyed Hashem Sezavar

Department of Cardiology, School of Medicine AND Research Center for Prevention of Cardiovascular Endocrinology and Metabolism, Research Institute Hazrate Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran

Farah Bokharaei-Salim

Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Angila Ataei-Pirkooh

Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Ahmad Tavakoli

Department of Virology, School of Medicine AND Research Center of Pediatric Infectious Diseases, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran

Davod Javanmard

Infectious Disease Research Center, Birjand University of Medical Sciences, Birjand, Iran

Javid Sadri-Nahand

Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Seyed Jalal Kiani

Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Hadi Ghaffari

Department of Bacteriology and Virology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran

Leila Beikzadeh

Department of Medical Laboratory Sciences, School of Paramedicine, Alborz University of Medical Sciences, Karaj, Iran

Latif Hamidpoor

Iranian Blood Transfusion Organization, Tehran, Iran

Seyed Hamidreza Monavari

Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran